The purpose of this study was to determine whether gamma delta T cells were
able to regulate graft-vs-host (GVH) reactivity mediated by alpha beta T c
ells in murine recipients transplanted with MHC-mismatched marrow grafts. S
tudies were conducted using ex vivo-activated gamma delta T cells because t
his was a more clinically relevant strategy, and these cells have been show
n to be capable of facilitating alloengraftment without causing GVH disease
(GVHD). Coadministration of activated gamma delta T cells and naive alpha
beta T cells at the time of bone marrow transplantation (BMT) significantly
exacerbated GVHD when compared with naive cup T cells alone. In contrast,
when the administration of naive alpha beta T cells was delayed for 2 wk po
st-BMT, survival was significantly enhanced in mice transplanted with BM pl
us activated gamma delta T cells vs those given marrow cells alone. Mitigat
ion of GVHD by activated gamma delta T cells occurred only at high doses (1
50 x 10(6)) and was a unique property of gamma delta T cells, as activated
alpha beta T cells were incapable of ameliorating the subsequent developmen
t of GVHD. Protection from GVHD was not due to the direct inhibition of nai
ve alpha beta T cells by gamma delta T cells, Rather, gamma delta T cells m
ediated this effect indirectly through donor BM derived alpha beta T cells
that acted as the proximate regulatory population responsible for the decre
ase in GVH reactivity. Collectively, these data demonstrate that activated
gamma delta T cells are capable of modulating the ability of MHC-incompatib
le nontolerant alpha beta T cells to cause GVHD after allogeneic BMT.